Orbimed Advisors - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$78,655,000
-0.2%
6,069,0320.0%0.80%
+8.0%
Q1 2021$78,806,000
+19.9%
6,069,032
+27.7%
0.74%
+28.2%
Q4 2020$65,748,000
-6.1%
4,754,0000.0%0.58%
-34.7%
Q3 2020$70,026,000
+260.2%
4,754,000
+297.4%
0.88%
+221.2%
Q2 2020$19,441,000
+0.2%
1,196,347
-10.5%
0.27%
-16.0%
Q1 2020$19,393,000
-59.2%
1,336,547
-43.0%
0.33%
-51.9%
Q4 2019$47,519,000
+152.0%
2,345,447
-33.6%
0.68%
+89.4%
Q3 2019$18,856,000
-18.8%
3,531,0020.0%0.36%
-0.6%
Q2 2019$23,234,000
+13.5%
3,531,002
+12.1%
0.36%
+13.6%
Q1 2019$20,474,000
+2071.2%
3,149,810
+1781.4%
0.32%
+2781.8%
Q2 2018$943,000
-71.0%
167,419
-73.3%
0.01%
-72.5%
Q1 2018$3,250,000
-60.1%
626,275
-65.2%
0.04%
-61.2%
Q4 2017$8,142,000
-27.8%
1,797,4000.0%0.10%
-4.6%
Q3 2017$11,270,000
+2.3%
1,797,4000.0%0.11%
-6.1%
Q2 2017$11,018,000
-16.5%
1,797,4000.0%0.12%
-23.3%
Q1 2017$13,193,0001,797,4000.15%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 188,500$4,311,0003.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 334,500$7,647,0001.70%
IRONWOOD INVESTMENT MANAGEMENT LLC 131,760$3,013,0001.49%
NEA Management Company, LLC 3,069,834$70,207,0001.42%
Berry Street Capital Management LLP 575,000$13,151,0001.36%
Melqart Asset Management (UK) Ltd 916,321$20,956,0001.06%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$2,287,0000.93%
HighMark Wealth Management LLC 50,499$1,155,0000.73%
Artal Group S.A. 1,000,000$22,870,0000.62%
Vigilare Wealth Management 34,925$799,0000.47%
View complete list of AURINIA PHARMACEUTICALS INC shareholders